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ACL = anterior cruciate ligament; bFGF = basic fibroblast growth factor; FDP = flexor digitorum profundus; TGF = transforming growth factor;
VEGF = vascular endothelial growth factor; VEGFR = vascular endothelial growth factor receptor.
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Introduction
Evidence exists that tendon repair can occur either intrinsi-
cally via the resident tenocytes [1,2] or via extrinsic mecha-
nisms, whereby cells from the surrounding sheath or
synovium invade the tissue [3]. It seems likely that both
mechanisms occur, although the involvement of external cells
depends on the site of injury and vascular perfusion. Many in
vivo animal studies have been performed on the ability of
tendon to repair following laceration, transection and other
models of injury [4–7]. A large number of in vitro studies on
animal and human tendon have also been performed
[1,2,8,9]. The roles of many factors in tendon repair have
been examined, including cell proliferation and DNA synthe-
sis [10,11], collagen [11], noncollagenous protein [12] and
proteoglycan synthesis [13]. Intratendinous degenerative
change is strongly associated with both chronic
tendinopathies and spontaneous tendon rupture [14–17].
Degeneration and subsequent rupture of tendons has
been associated with hypovascularity of specific regions
within certain tendons [18,19]. A permanent disruption of
the central blood vessels to normal tendons has been
shown to cause cellular death and disintegration of colla-
gen bundles [20]. Contradictory to this, however, would
appear to be the finding that in many cases of chronic
tendinopathy that have been examined histologically, there
is an ‘angiofibroblastic’ response, and the presence of
many large blood vessels [21–23]. The presence of blood
vessels was not considered to be an indication of tissue
repair [22]. What then is the role of a proliferative vascula-
ture in the damaged tendon?
The aim of this review is to discuss the importance of the
vasculature in tendon damage and repair, and what is
known about factors that regulate changes in the vascula-
ture of what is normally a sparsely vascularised tissue.
Tendon vasculature
During development, tendons are highly cellular and meta-
bolically active, and are thus supplied with a rich capillary
network [20]. Mature tendons, however, are poorly vascu-
larised [24–26]; tendon nutrition is more reliant on syn-
ovial fluid diffusion than vascular perfusion [27], although
they do have more blood vessels than is commonly
accepted. Like any other connective tissue, tendon does
not undergo neovascularisation under normal circum-
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Abstract
Tendon pathology has many manifestations, from spontaneous rupture to chronic tendinitis or
tendinosis; the etiology and pathology of each are very different, and poorly understood. Tendon is a
comparatively poorly vascularised tissue that relies heavily upon synovial fluid diffusion to provide
nutrition. During tendon injury, as with damage to any tissue, there is a requirement for cell infiltration
from the blood system to provide the necessary reparative factors for tissue healing. We describe in
this review the response of the vasculature to tendon damage in a number of forms, and how and when
the revascularisation or neovascularisation process occurs. We also include a section on the
revascularisation of tendon during its use as a tendon graft in both ligament reconstruction and
tendon–tendon grafting.
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stances. The vascular supply of specific tendons, and the
sources of the vasculature within each tendon, has been
described in detail elsewhere [18–20,24–26,28–35].
The vascular supply to the tendon has been shown to arise
from three distinct areas: the musculotendinous junction;
the osseotendinous junction; and vessels from various sur-
rounding connective tissue such as the paratenon,
mesotenon and vincula [24,26,30,32]. Vessels are gener-
ally arranged longitudinally within the tendon, passing
around the collagen fibre bundles in the endotenon, a
sheet of loose connective tissue contiguous with the exter-
nal layer or epitenon [20,31,32] (Fig. 1). In the hand
tendons, very few straight vessels are seen [24], and these
tend to be curved allowing them to straighten out during
tendon movement [32]. Vessels at the bone insertion do
not pass directly through from the bone into the tendon
due to a cartilage layer between the tendon and bone [25],
but they anastomose with those of the periosteum, forming
an indirect link with the osseous circulation [31].
A number of arteries may be responsible for contributing
to the blood supply of a tendon. For instance, six arteries
supply blood to the rotator cuff tendons [30], branches of
the peroneal and posterior tibial arteries supply the
Achilles tendon [25], and four artery branches have been
shown to supply the digital flexors [28]. There are,
however, significant differences between the vascular sup-
plies of different tendons; for instance each of the four
tendons of the rotator cuff complex show a different vas-
cular pattern [19]. There are also differences between
‘round’ tendons, such as the Achilles tendon, and those of
the rotator cuff, and ‘flat’ tendons such as the patella
tendon [19]. In particular, there is a significant difference
between tendons that are contained within a sheath, and
those that are unsheathed [32,33]. In unsheathed
tendons, vessels may pass through the surrounding
paratenon into the tendon at any point along the tendon.
Sheathed tendons, however, have a much better defined,
vincular supply; the blood vessels enter the tendon only at
specific points along the tendon [32,33] (Fig. 1).
A number of tendons (but not all) appear to have regions
of reduced vascularity, including the supraspinatus
[19,34], biceps tendon [19], Achilles tendon [25,35],
patella tendon [36] and posterior tibial tendon [18]. These
avascular zones are commonly associated with degenera-
tion and rupture, although there is no direct evidence to
suggest that hypovascularity is a primary cause of tendon
rupture. Degeneration of the supraspinatus has been
attributed to ageing [37], although this does not explain
why other rotator cuff tendons, also with hypovascular
regions, do not share a similar predisposition to pathology.
The region of avascularity has been particularly studied in
the supraspinatus, which is termed ‘Codmans critical zone’
after first being described by Codman and Akerson in
1931 [38]. However, this zone is not essentially avascular,
and indeed intrinsic vessels of this zone have been shown
to become filled with fluid once the tendon is removed from
the compression applied by the humeral head [34]. Zones
of avascularity within tendons may not be as clear cut as it
would seem; the lack of blood penetration to these areas
may be due to extrinsic factors such as regions of com-
pression, as opposed to a simple lack of blood vessels. It
seems likely that a combination of factors is responsible for
predisposing a tendon to degeneration and/or rupture.
Neovascularisation of tendon
Tendon grafts
Although not essentially a pathological condition, the neo-
vascularisation of tendon during its use as a tendon graft
has been widely studied in both human and animal
Figure 1
The structure and vascular supply of tendon. (a) The hierarchical
structure of a typical tendon, composed of bundles of collagen fibrils
bound together into fibres by the endotenon and surrounded by the
epitenon. Adapted from Connective Tissue Research [94]. (b)
Diagram showing the vincula supply to the sheathed digital flexor
tendons (grey line with arrowheads). Published with permission from
Journal of Bone and Joint Surgery [32]. (c) The supplying artery forms
branches (mesotenon) into the tendon, passing through the sheath at a
number of sites. Published with permission from Grant’s Atlas of
Anatomy [95]. (d) Blood vessels are arranged longitudinally in the
epitenon, with frequent cross-anastomoses, and pass through the
endotenon surrounding the fibre bundles (fascicles). Published with
permission from Journal of Bone and Joint Surgery [32].
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models, and this model allows us to study the process of
tendon neovascularisation per se. The patellar tendon is
often used as an autograft to reconstruct or replace the
anterior cruciate ligament (ACL) or posterior cruciate liga-
ment [36,39–43]. The properties required for a tissue to
replace the ACL have been discussed [44], one of these
was concluded to be the need for a vascular supply. The
advantages of using the patellar tendon as a cruciate liga-
ment graft have been described [45] and the patellar
tendon graft is the only autogenic transplant shown to
have the strength and mechanical properties similar to
those of normal cruciate ligaments [46]. The long-term
survival of a patellar tendon graft is thought to be depen-
dent on revascularisation of the graft [47,48]. Paulos et al.
discussed that as much of the blood supply of the patellar
tendon as possible should be preserved to maintain viabil-
ity and facilitate the revascularisation process [45].
Studies have shown that the vascularisation of patellar
tendon transplants occurs in relation to time in a number
of models, including rabbit [48], dog [49,50], sheep
[42,43], monkey [36] and human [47,51]. The vascularisa-
tion of patellar tendons used as cruciate ligament grafts
has been examined over lengthy time periods [42,43,52],
and up to 6.5 years in one human study [51].
The stages of graft revascularisation have been charted
and described by a number of investigators [42,43,49].
Initially nutrition of the graft is thought to occur through dif-
fusion of nutrients from the adjacent synovial tissue and
synovial fluid [48,53]. The primary stage of graft vasculari-
sation, which occurs in the first two weeks, is a surround-
ing of the graft material by a thick, richly vascularised
loose connective tissue. Vascular invasions are present in
the periphery of the graft, however regions of ischemic
necrosis in the mid-substance of the grafts were also seen
[42,43]. By 6 to 10 weeks, the graft had become revascu-
larised [42,43,49], with intrinsic vessels seen originating
in the proximal and distal portions of the patellar tendon
graft, and migrating centrally. Areas of necrosis could still
be seen at this stage [49]. Complete revascularisation of
grafts was seen to occur by 16–20 weeks, and by
26 weeks the vascular response had subsided [49].
Longer term analysis up to 52 and 104 weeks showed a
paucity of blood vessels, as is usually seen in normal cru-
ciate ligaments [42,43]. The main sources of vessels for
the revascularisation process are the endosteal vessels of
both the femur and the tibia [36], the infrapatellar fat pad,
and the synovial tissues [49]. The revascularisation of a
patellar tendon graft is considered to be one of the four
transitional phases of tendon patellar graft healing, as
described by Kasperczyk et al. [42]. The revascularisation,
or ‘revitalisation’, stage is the second of the four stages,
and is considered to start at six weeks post surgery.
Original work by Whiston and Walmsley [54] showed that
grafted tendon left for lengthy periods of time becomes
histologically identical to the original tendon. Amiel et al.
[48] described that a patellar tendon placed in the
anatomical and environmental milieu of the ACL becomes
‘ligamentised’, and this has been supported by Rougraff et
al. [51]. However, Bosch et al. [43] claim that this auto-
grafted tissue does not in fact undergo ‘ligamentisation’,
but only develops into a partially organised replacement
tissue. Even after two years, the tissue was structurally
and mechanically different from a normal ligament.
The use of auto- or allografts makes very little difference to
the cellular repopulation and revascularisation of tendon
grafts when used in cruciate ligament reconstruction. Allo-
grafts are freeze–thawed to destroy potential immunologic
complications before grafting. These grafts showed a
similar revascularisation rate as studies described using
autografts [36,39,42,43,49].
Along with the use of tendon as a graft for the ACL and/or
posterior cruciate ligament, tendons have also been used as
grafts to replace other tendons [55–57]. Much of the exper-
imental work has investigated the best source of tendon for
grafting. The source of donor tendon has been shown to
affect the state of new blood vessel growth and infiltration
into the graft [58–60]. Intrasynovial (peroneus longus) and
extrasynovial (flexor digitorum profundus [FDP]) tendon
donors were grafted into the synovial sheaths in the
forepaws of dogs [59]. The extrasynovial grafts were shown
to vascularise along with the ingrowth of vascular adhe-
sions, while intrasynovial grafts healed with a minimum of
vascular ingrowth. It was concluded that the ability of flexor
tendon grafts to heal without adhesions is at least partially
donor tissue specific. Similar work performed by Seiler et al.
[58], also in dogs, showed the formation of vascular adhe-
sions by extrasynovial grafts, while intrasynovial grafts
healed with a minimum of adhesion, with neovascularisation
originating from the proximal and distal sites of repair. Work
by Eiken and Lundborg [61] has also stressed the impor-
tance of the tendon sheath in tendon grafting procedures.
The profundus tendon of the third chicken toe was trans-
ferred into the fourth toe in either an intact or an excised
sheath. The tendons placed into intact sheaths did not form
adhesions while those in the excised sheath did. The vascu-
lar pattern seen in the tendon of the intact sheath reflected
that of a normal profundus tendon by 16 weeks. It was con-
cluded that an intact digital sheath nourishes the graft and
prevents the need for adhesion formation.
Differences between sources of vascularised and nonvas-
cularised tendon grafts have also been compared. Singer
et al. [60] compared seven vascularised and eight non-
vascularised tendon grafts in monkeys. Although the vas-
cularised tendons appeared to show the formation of
fewer adhesions, there was generally little difference
between the two tendon sources. However, experimental
numbers were small.
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The vascularisation of autogenic tendon grafts is vital to
allow the tendon to function as a ligamentous structure or
as an alternative tendon. Although the source of blood
vessels and the timescale of vascularisation have been
examined, the cellular factors that are responsible for
mediating the process have not been investigated, and
there is a large gap in our knowledge regarding how the
revascularisation of such grafts is controlled.
Acute injury
Much of the experimental work on tendon repair has con-
centrated on various methods of repairing complete or
partial tendon lacerations. However there is actually little
mention of changes in vascularisation associated with the
repair process. Matthews [6] attempted to address the
lack of information about circulation in repairing tendon
using an injection technique. In a New Zealand white
rabbit model that had undergone a closed tenotomy of the
FDP tendon, he showed a plexus of fine new vessels
forming at the tip of lacerated tendons. Adhesions that
formed between tendons and the surrounding connective
tissues were also shown to be highly vascularised.
Increased vascularity at the tendon stump following
tendon division and suture has also been shown in the
flexor tendon of the canine forefoot [3]. Capillary buds
were seen to invade the tendon at focal breaks made by
the suturing process. Gelberman et al. [10] showed an
initial vascular response in tendon injury of the dog FDP
that was profuse and haphazard, and stated that the early
stages of repair were characterised by a marked increase
in vascularity. Kakar et al. [62] noted neovascularisation in
the tendon sheath and epitenon of the FDP in the New
Zealand white rabbit model after partial plantar laceration,
although there was no mention of any vascularisation
within the endotenon. Richards [63] showed that within a
few hours of digital flexor tendon injury or division, the
mesotenon could be seen carrying leashes of dilated
blood vessels to the injured tendon. He also showed that
impairment of tendon healing occurs if there is a diminu-
tion of the blood supply. The proximal end of the divided
tendon stump showed cell and tissue necrosis.
Chronic tendinopathy
Chronic painful tendon pathology (tendinopathy), often
referred to as a tendinitis, is perhaps more accurately
described as a tendinosis, reflecting the absence of an
inflammatory process [14–17,22]. The cause of chronic
tendinopathy is unknown, although alterations in the histol-
ogy, histochemistry and biochemistry of such lesions have
been extensively studied [12–17,22,64,65]. A number of
studies have shown an increase in vascularity at the site of
chronic painful tendon lesions [22,23]. However, these
lesions were found consistently at a point where the blood
supply in the normal tendon is poorest [66]. Indeed rotator
cuff disease of the shoulder, particularly of the supraspina-
tus tendon, has generally been considered a consequence
of its avascular region [67,68], although this is not neces-
sarily the case (as discussed earlier). The changes seen
during chronic tendon degeneration were shown to be the
same as those that occur when the blood supply in the
Achilles tendon is disrupted [67]. It was hypothesised
that, due to an impoverished vascular supply to the inser-
tion region, a portion of the tissue may die, resulting in
tissue degeneration [67].
A study by Astrom and Rausing [22] on biopsies from 163
patients with Achilles tendinopathy, demonstrated hyper-
vascularity of the tendon, with groups of thick walled
vessels distributed unevenly compared to biopsy speci-
mens of macroscopically normal tissue from a nonsympto-
matic area. This hypervascularity, however, was not
thought to be associated with tissue repair. A study in a
rabbit model of Achilles paratenonitis and tendinosis [69],
using radiolabeled microspheres, showed that blood flow
is increased in the damaged tendon compared to control
tendons [70]. It was concluded that the degenerative
alterations within the tendon and paratenon were not due
to a chronic circulatory impairment, although measure-
ments of blood flow during actual exercise were not per-
formed. Two histopathologic studies of the patellar tendon
in chronic patellar tendinosis or ‘jumpers knee’ showed
capillary proliferation and prominent angiogenesis in the
degenerate region [21,71]. The abnormal tissue was
shown to correlate well with magnetic resonance findings
[21]. The paratenon is also a site of chronic pain, and has
been shown to undergo marked neovascularisation and
degenerative vascular changes [23,70]. It was suggested
that vascular alterations of the paratenon disturb the blood
supply and cause ischemic pain during exercise [23].
Chronic tendon pathology would therefore seem to be a
highly active process in terms of neovascularisation of the
tissue. Why this hypervascular state (and the associated
tendinopathy) fails to resolve is unknown, and the invasion
and proliferation of new blood vessels may be a contribu-
tory factor to the pain and chronicity of the disease.
Spontaneous tendon rupture
Spontaneous tendon rupture (the sudden rupture of a
tendon without preceding clinical symptoms) is a relatively
common occurrence in sports, particularly in the recre-
ational athlete [72]. Studies have shown the presence of
tendon degeneration at the sites of tendon rupture, at time
points soon after the rupture, which suggests that the
degeneration was not a secondary event [73,74]. Indeed
it is now generally accepted that tendon degeneration
causes the rupture and does not result from it [17,75].
However, there are some studies that question the rela-
tionship between tendon degeneration and tendon
rupture. A study by Williams [76] for instance found no
complete ruptures of the Achilles tendon in patients with
chronic Achilles tendinopathy, suggesting that degenera-
tion does not inevitably lead to rupture. Barfred [77] sum-
Available online http://arthritis-research.com/content/4/4/252
256
marised much of the early work on tendon ruptures, some
of which claims that degeneration occurs prior to rupture,
others that did not show prior degeneration. A rat model,
described by Barfred, showed that after rupture there was
no alteration in the blood vessels either within or around
the tendon. He further showed that prior degeneration
was not a necessary precondition for tendon rupture [78].
There is, however, strong evidence that partial tear and
ruptures of a tendon are a consequence of tendon matrix
degeneration; tendon degeneration is seen in partially rup-
tured tendons [67,79]. A study by Kannus and Jozsa [17]
of 891 spontaneously ruptured tendons showed the pres-
ence of degeneration in all tendons, with none showing a
normal tendon structure. After examining two cases of
tendon rupture taken immediately postrupture, Davidsson
and Salo [73] showed degenerative and necrobiotic
changes along with inflammatory and regenerative
changes, which were considered to have occurred prior to
the rupture. It was suggested that vascular changes due
to age and activity are an influencing factor on the degen-
eration of tendon that ultimately led to rupture. Arner and
Lindholm [80] also saw vascular changes in some rup-
tured tendons, although samples were taken at more than
two weeks postrupture, and these changes were consid-
ered to be a secondary result of an inflammatory, regener-
ative process.
In summary, there is uncertainty regarding the role of the
vasculature in the processes underlying tendon rupture
and tendon degeneration. However, there are generally
differences in vascularity between chronic tendinopathy
and those tendons that rupture ‘spontaneously’. Chronic
painful lesions show degeneration coinciding with blood
vessel infiltration and cell proliferation without much indi-
cation of tissue repair [22]. Spontaneous ruptures do not
show much evidence of vascularisation or cell prolifera-
tion, although they are also associated with degeneration
of the tissue [17].
We suggest two possible consequences of tendon
damage, which are summarised in Figure 2. The clinical
condition of chronic tendinopathy, which manifests primar-
ily as pain, shows vascular infiltration and cell proliferation
within the tendon. In contrast, in the subclinical condition
preceding spontaneous tendon rupture, there is a failure
to elicit a vascular response. Indeed the lack of vascularity
is possibly one of the causative factors. The tendon
degenerates and ultimately results in weakened tissue,
which subsequently ruptures. The factors influencing the
response of the tendon are unknown and are represented
by the black box in Figure 2.
Angiogenic factors and tendon injury
Very little is known about growth factors and cytokines
expressed in tendon wound healing and repair, although
there have been a few studies [81–85]. Chang et al. [84]
used immunolocalisation and in situ hybridisation to quan-
tify the presence of basic fibroblast growth factor (bFGF)
in a rabbit model of flexor tendon wound healing. They
showed a significantly elevated number of cells in both the
tendon substance and the epitenon expressing this angio-
genic growth factor. It was suggested that the bFGF
upregulation may represent an early, sustained signal for
angiogenesis. This growth factor has also been shown to
be present in uninjured canine flexor tendons through its
binding to heparin–sepharose columns [85] and an
increase in staining for bFGF has been shown in the early
postoperative period after autogenous patellar tendon
grafting used to reconstruct the ACL [86].
Platelet derived growth factor, epidermal growth factor
and transforming growth factor (TGF)-β1 have also been
shown to be upregulated during tendon wound repair and
grafting [82,83,85]. Their roles are most likely to be
involved in the revascularisation of the tendon [82,84].
Vascular endothelial growth factor (VEGF), the prototypic
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Figure 2
Schematic diagram illustrating two basic consequences of tendon
damage. We postulate that the abundant neovascularisation in chronic
tendinopathy is responsible for the clinical symptoms (pain, swelling).
In the absence of a vascular response, the degenerative process is
asymptomatic, and may lead directly to tendon rupture. Subclinical
degeneration may also lead to the clinical condition of tendinopathy.
Painful tendinopathy, however, does not necessarily lead to tendon
rupture. The black box signifies our lack of understanding of the
processes that distinguish these two potentially different pathways.
TENDON DAMAGE
Chronic
tendinopathy
Tear/rupture
??
??
Clinical symptoms
Pain, swelling
Subclinical damage
Asymptomatic
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angiogenic growth factor, has also been localised to cells
in the early stage of tendon wound healing. Bidder et al.
[81], using in situ hybridisation in a canine model of
tendon injury, identified cell populations within the repair
site expressing message for VEGF, suggesting their
potential for organising the angiogenic response during
the early postoperative phase of wound healing. The distri-
bution of growth factors in tendon healing, however, has
not been thoroughly researched and many more questions
need to be answered regarding the growth factor and
cytokine profile of both normal and pathological tendon. It
should also be noted that there is a paucity of literature
describing the distribution of receptors for potential angio-
genic growth factors, such as those for VEGF (VEGFR-1,
VEGFR-2 and VEGFR-3), and receptors for those growth
factors that may be involved in tendon repair, such as
bFGF and platelet derived growth factor. The latter have
been shown to regulate αvβ3 and α5β1 integrin expres-
sion in tenocytes, which have a function in angiogenesis
[87]. An understanding of when and where these growth
factors and their receptors are expressed would help us to
further determine the role that they play in tendon injury
and pathology. We suggest the need for similar investiga-
tions to those that have been performed in ligament,
where the profile of growth factor induction and expres-
sion during injury and repair have been more extensively
investigated [88,89].
Conclusion
The main points of this review are summarised in Table 1.
Although the relative roles of vascular perfusion and syn-
ovial fluid diffusion as mechanisms of tendon nutrition
during the healing of tendon is still not clear [85], it is
thought that flexor tendons are nourished to a greater
extent by synovial fluid diffusion [27]. However, this review
illustrates not only the importance of vascularisation of
tendons during their attempts at healing and integration
when used as grafts, but also brings into question its role
in chronic tendon lesions and tendon degeneration. It
seems apparent that, despite an increase in the number of
blood vessels in chronic tendon pathologies [22,23], there
is very little suggestion of a healing response [22]. The
role that the vasculature plays in certain tendon patholo-
gies is therefore an open question and sheds doubt onto
whether vascular invasion of tendon is, in fact, a desirable
thing under some circumstances.
In many patients the degenerative processes does not
manifest clinically, with no symptoms such as pain or
swelling. In a survey of 891 ‘spontaneous’ ruptures,
Kannus and Jozsa found that two-thirds of the patients had
no symptoms prior to rupture [17]. Why there is a lack of
clinical symptoms is unknown, but may be related to the
absence of nerve endings in the (relatively) avascular
tendon. We postulate that the initial insult does not always
trigger a vascular or fibroproliferative response, resulting in
an absence of inflammation and/or pain. It may be that
there is a limited cellular response in these tissues,
perhaps because the cells are terminally differentiated, qui-
escent, senescent or possibly dead. There may be no
release of factors that are necessary to promote cell activ-
ity. If there is a vascular response, perhaps because trauma
or damage reaches an area where vessels are present,
then painful tendon symptoms may develop, with ingrowth
of blood vessels and fibroblast proliferation. The source of
the pain in tendinopathy is unknown, whether derived from
sensitised nerve endings within the tendon or in the sur-
rounding peritendinous tissues. In other tissues, such as
the intervertebral disc, ingrowth of blood vessels is associ-
ated with ingrowth of nerves [90], but very little is known
about the innervation of degenerate and painful tendons.
Available online http://arthritis-research.com/content/4/4/252
Table 1
Summary of the main points of the tendon vasculature in repair and pathology
Condition Observations
Tendon grafts Neovascularisation is essential for long term survival of graft
Potential model for study of neovascularisation in tendon injury and pathology
Acute injury Lack of knowledge of timing and control of the vascular response
Increased vascularity at tendon stump following resection
Initial vascular response is profuse and haphazard
Diminution of blood supply results in impairment of repair process
Chronic tendinopathy Increased vascularity is associated with chronic (painful) tendon lesions
Hypervascularity is apparently not associated with signs of attempted repair
Hypervascularity may be a contributory factor to pain and chronicity of tendon lesions
Spontaneous tendon rupture Degeneration occurs before rupture without preceding clinical symptoms
There is usually no evidence of a vascular response
Absence of blood vessels is responsible for absence of pain and symptoms 
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It is apparent that many etiological factors and pathways
may be responsible for tendon degeneration [72]. One
potentially important factor is hypoxia in the tendon, and
how this relates to vascularisation. As tendon is a rela-
tively sparsely vascularised tissue, it has been suggested
that hypoxia may be a cause of tissue degeneration and
subsequent rupture in tendons [14–19,67,68,91]. The
ability to measure oxygen tensions within tendon [92]
may help us to further understand the role that local
hypoxia has in tendon degeneration. With respect to neo-
vascularisation as part of this process, VEGF has been
shown to function as a hypoxia-inducible factor [93],
potentially providing a link between ischaemia/hypoxia
and tendon neovascularisation.
The angiogenic process is mediated by a vast milieu of
growth factors and cytokines, yet very little work has been
done to investigate the presence and role of these
growth factors and cytokines in normal, injured and
healing tendon. Although the presence of angiogenic
factors has been shown in healing tendon [81,84], there
have been few attempts made to examine the growth
factor profile of normal and pathological tendons. There
is, therefore, a large gap in our knowledge concerning
how the vascularisation process in tendon is controlled.
This knowledge is necessary if we are to understand why
a vascular response in chronic tendinopathy apparently
does not lead to repair or resolution of the condition,
while revascularisation of tendon grafts allows normal
function of the tissue.
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